Microbix Biosystems Inc. (TSE:MBX – Get Free Report)’s share price passed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of C$0.34 and traded as high as C$0.34. Microbix Biosystems shares last traded at C$0.34, with a volume of 4,390 shares.
Microbix Biosystems Trading Down 1.5 %
The firm has a market capitalization of C$45.79 million, a PE ratio of 8.38 and a beta of 0.37. The company has a quick ratio of 5.57, a current ratio of 6.62 and a debt-to-equity ratio of 22.68. The company’s 50-day simple moving average is C$0.34 and its 200 day simple moving average is C$0.34.
Insider Activity at Microbix Biosystems
In other news, insider Microbix Biosystems Inc. purchased 600,359 shares of the business’s stock in a transaction on Friday, August 30th. The shares were acquired at an average cost of C$0.34 per share, with a total value of C$204,122.06. 14.53% of the stock is currently owned by corporate insiders.
Microbix Biosystems Company Profile
Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.
Featured Articles
- Five stocks we like better than Microbix Biosystems
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- What is Forex and How Does it Work?
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Microbix Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbix Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.